Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,32 USD | -2,23% | -1,50% | +68,14% |
Attività
Numero di dipendenti: 18
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Or Eisenberg
DFI | Director of Finance/CFO | 43 | 01/06/21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/12/21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01/01/22 |
Corporate Officer/Principal | - | 01/03/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 56 | 21/12/21 | |
Chairman | 67 | 01/10/21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01/12/21 |
Director/Board Member | 49 | 01/01/22 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 21/12/21 |
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 17 334 042 | 12 382 922 ( 71,44 %) | 0 | 71,44 % |
Coordinate società
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+68,14% | 23,4 Mln | |
-1,70% | 102 Mrd | |
+2,45% | 96,09 Mrd | |
+2,13% | 22,28 Mrd | |
-16,75% | 21,4 Mrd | |
-8,79% | 18,14 Mrd | |
-39,98% | 17,02 Mrd | |
-14,17% | 16,09 Mrd | |
+5,23% | 13,83 Mrd | |
+33,13% | 11,97 Mrd |
- Borsa valori
- Azioni
- Azione NRSN
- Società NeuroSense Therapeutics Ltd.